Over the last few years, the transplant diagnostics market has witnessed significant growth owing to the ongoing development and commercialization of novel transplant diagnostic products (such as PCR based instruments, reagents for molecular and non-molecular assay procedures, and consumables, among others). Growing number of solid organ, tissue, and stem cell transplantation procedures; ongoing technological advancements in the field of donor-recipient profiling and cross match; and growing awareness among healthcare professionals about the benefits offered by molecular assay techniques are the key factors driving the growth of the global transplant diagnostics market.
In 2016, North America is expected to account for the largest share of the transplant diagnostics market. However, the Asia-Pacific region is projected to grow at the highest CAGR during the forecast period. Market growth in the Asia-Pacific region is augmented by the rapid rise in geriatric population (especially in Japan and China), presence of a well-developed healthcare system in Japan, rising government expenditure in China and India to modernize & expand their healthcare infrastructure, significant prevalence of chronic diseases in India and China, and growth in medical tourism across RoAPAC countries.
On the basis of technology, the transplant diagnostics market is segmented into non-molecular assay and molecular assay (PCR based and sequencing based). The PCR based segment is expected to account for the largest share of the market in 2016. This growth can be attributed to the expanding distribution networks of key PCR manufacturers across emerging countries, increasing private funding to develop innovative PCR-based products, and ongoing development and commercialization of innovative PCR-based products for donor-recipient compatibility testing.
On the basis of products and services, the global transplant diagnostics market is segmented into instruments, reagents & consumables, and software and services. The instruments segment is expected to command the largest share of the market in 2016. Factors such as ongoing technological advancements in the field of transplant diagnostics, increasing awareness regarding benefits offered by genome-based donor-recipient profiling (as compared to serological assays), and increasing commercialization of innovative transplant diagnostic instruments are driving the growth of this market.
On the basis of application, the transplant diagnostics market is segmented into research applications and diagnostic applications. The diagnostic applications segment is further divided into infectious disease diagnostics, histocompatibility testing, blood profiling, and research applications. In 2016, the diagnostic applications segment is expected to account for the largest share of the market. Growth in this segment is majorly driven by the rising number of solid organ, soft tissue, and stem cell transplantation procedures; ongoing technological advancements; rising adoption of transplant diagnostic techniques among hospitals & transplant centers; growing investments; and increasing awareness among the public (in developed countries) about the importance of organ transplantation procedures.